BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shiri T, Evans M, Talarico CA, Morgan AR, Mussad M, Buck PO, Mcewan P, Strain WD. The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program. Vaccines 2022;10:140. [DOI: 10.3390/vaccines10020140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Reifferscheid L, Lee JSW, Macdonald NE, Sadarangani M, Assi A, Lemaire-paquette S, Macdonald SE. Transition to endemic: acceptance of additional COVID-19 vaccine doses among Canadian adults in a national cross-sectional survey. BMC Public Health 2022;22. [DOI: 10.1186/s12889-022-14025-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kohli MA, Maschio M, Lee A, Fust K, Van de Velde N, Buck PO, Weinstein MC. The Potential Clinical Impact of Implementing Different COVID-19 Boosters in Fall 2022 in the United States.. [DOI: 10.1101/2022.07.19.22277824] [Reference Citation Analysis]
3 Tan KYK, Soh ASE, Ong BWL, Chen MI, Griva K. Determining the Prevalence and Correlates of COVID-19 Booster Vaccine Hesitancy in the Singapore Population Following the Completion of the Primary Vaccination Series. Vaccines 2022;10:1088. [DOI: 10.3390/vaccines10071088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ryan M, Montgomery J. Myopericarditis after COVID-19 vaccination: unexpected but not unprecedented. The Lancet Respiratory Medicine 2022;10:624-5. [DOI: 10.1016/s2213-2600(22)00091-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fadul A, Abdalla E, Abdelmahmuod E, Abdulgayoom M, Ali E, Al-warqi A, Al-yahary H. COVID-19 Vaccine-Induced Cerebral Sinus Thrombosis: Coincidence vs. Cause? Cureus 2022. [DOI: 10.7759/cureus.26436] [Reference Citation Analysis]
6 Reifferscheid L, Wun Lee JS, Macdonald NE, Sadarangani M, Assi A, Lemaire-paquette S, Macdonald SE. Transition to Endemic: Acceptance of Additional COVID-19 Vaccine Doses Among Canadian Adults in A National Cross-Sectional Survey.. [DOI: 10.1101/2022.06.27.22276870] [Reference Citation Analysis]
7 Nashwan A, Yassin M, Soliman A, De Sanctis V, Ibrahim M. mRNA-based COVID-19 Vaccines Booster Dose: Benefits, Risks and Coverage. Acta Biomed 2022;93:e2022236. [PMID: 35775753 DOI: 10.23750/abm.v93i3.13103] [Reference Citation Analysis]